Loading...
NPI 1790163772 · Juana Diaz, PR · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Fresenius Vascular Care Del Caribe, Inc is a ambulatory surgical clinic/center provider located in Juana Diaz, Puerto Rico. This profile covers 3 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Fresenius Vascular Care Del Caribe, Inc |
| Address | Carretera 584 Km 0.4 |
| City | Juana Diaz |
| State | PR |
| ZIP | 00795 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | May 11, 2015 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $86.7K |
| Medicaid | $0 |
This entity is registered under the Ambulatory Surgical Clinic/Center taxonomy and bills almost exclusively for procedures that maintain and revise dialysis vascular access; the top Medicare codes are 36902 (angioplasty/angiography of dialysis access), 36832 (arteriovenous fistula revision), and 36589 (removal of tunneled central venous access device). The code mix indicates an outpatient interventional vascular access operation focused on dialysis access management rather than a broad surgical practice.
Medicare revenue for the provider totals $86.7K and the precomputed top-3 concentration shows those three codes account for 100.0% of that Medicare revenue. At the code level, 36902 contributes $69.1K (79.8%), 36832 contributes $15.4K (17.8%), and 36589 contributes $2.1K (2.4%), demonstrating a heavy reliance on a single service line.
Payer mix is effectively single-payer in the available data: Medicare revenue is $86.7K while Medicaid revenue is $0, meaning the provider’s billed activity in the dataset is entirely Medicare-based. This absence of Medicaid billing suggests the facility either does not serve Medicaid populations, bills them under different arrangements not captured here, or has no Medicaid activity in the reporting window.
For its top revenue-driving code 36902 the provider reported 57 claims, $1213 avg paid/claim, $69.1K revenue and ranks #534 of 1666 nationally (67th percentile; typical, unremarkable volume for this code), indicating a modest but not dominant national presence for dialysis-access angioplasty. The other codes also carry only typical statistical descriptors: 36832 has 11 claims, $1402 avg paid/claim, $15.4K revenue and ranks #223 of 256 (0th percentile; typical, unremarkable volume), and 36589 has 13 claims, $161 avg paid/claim, $2.1K revenue and ranks #1180 of 1598 (18th percentile; typical, unremarkable volume).
Average paid-per-claim contrasts are notable within the top three: $1213 avg for 36902 and $1402 avg for 36832 versus $161 avg for 36589, which signals that angioplasty and fistula revision drive revenue while tunneled catheter removal contributes low revenue per claim. Combined with claim counts of 57, 11, and 13 respectively, 36902 is both the highest-volume and highest-revenue procedure for this provider.
The provider’s NPI was enumerated on 2015-05-11 (~11 years ago), indicating it has been present in Medicare billing for over a decade. That tenure provides a modest historical window to assess stability of utilization and reimbursement patterns over time.
None of the top Medicare codes are flagged as statistical outliers in the provided descriptors; each is labeled as "typical, unremarkable volume," which mitigates immediate statistical concern. However, the fact that the top 3 codes make up 100.0% of Medicare revenue creates concentrated business risk if utilization or payment for these specific procedures were to decline.
Given the concentrated revenue profile centered on dialysis access interventions, payers and provider-network managers should monitor referral patterns and reimbursement trends for 36902 and 36832, because changes in utilization or payment policy for those codes would materially affect this provider’s Medicare revenue base. These characteristics make the provider a sensible candidate for periodic utilization review within networks focused on dialysis services.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36902 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 60 | $1,210 | $69.1K |
| 36832 | In this procedure, the provider surgically opens an autogenous or nonautogenous arteriovenous fistula and revises the connection between the artery and the vein often located in the upper arm or… | 10 | $1,400 | $15.4K |
| 36589 | In this procedure, the provider removes a tunneled central venous access device without the subcutaneous port or pump. | 10 | $160 | $2.1K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 3 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36902 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 10 | $0 | $0 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 20 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Puerto Rico providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Puerto Rico median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 36902 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 4 | 10 | 70 | $200 | $29.9K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 3 | 10 | 20 | $0 | $0 |
Other providers in the same ZIP code as Fresenius Vascular Care Del Caribe, Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Southern Hospital Services Inc | PR | Emergency Care Clinic/Center | $0 | $2.4M |
| Laboratorio Clinico Profesional Emanuel Inc | PR | Clinical Medical Laboratory | $9.8K | $2.4M |
| Awilda Vazquez Quintana | PR | Physical Therapist | $0 | $1.3M |
| Southern Hospital Service Inc | PR | Clinical Medical Laboratory | $0 | $1M |
| Laboratorio Clinico Irizarry Guasch Inc | PR | Clinical Medical Laboratory | $0 | $852.7K |
| Maria J Lopez Aguado | PR | Clinical Medical Laboratory | $1.9K | $835.2K |
| Quality Care Hospice LLC | PR | Community Based Hospice Care Agency | $0 | $777.9K |
| Dr Jose E Martinez Campos Csp | PR | Medical Specialty Clinic/Center | $0 | $637.1K |
| Sonia Mercado Cruz | PR | Clinical Medical Laboratory | $140 | $612.3K |
| Glenda Rodriguez | PR | General Practice Physician | $316.2K | $6.1K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.